The role of the NLRP3 inflammasome in hypertension-related chronic heart failure and its potential therapeutic targets

• by Feilong Sun, Xinyu Zhao, Chunlin Chen, Xue Ma, Fang Liu

• July 1, 2026

Outcome of Patients with Single Ventricles who Initially did not Indicate Fontan Completion After Stage II Palliation

• by Carolin Niedermaier, Cornelius Przybilla, Thibault Schaeffer, Muneaki Matsubara, Christina Ruda, Jonas Palm, Nicole Piber, Peter Ewert, Jürgen Hörer, Masamichi Ono

• July 13, 2026

Do Systemic Alpha-2 Agonists Lower Glaucoma Risk?

A large US cohort study found systemic alpha-2 agonist use was associated with a lower hazard of glaucoma-related diagnoses vs. beta-blockers.

• by Andrea Surnit

• July 8, 2026

• 3 min

Integrated management of atrial fibrillation and comorbidities in the community: a generalist-specialist collaborative RCT and subgroup analysis

• by Dai Huimin, Bo Jun, Jiang Meng, Zhou Lulu, Huang Qian, Ying Xiaoying

• July 13, 2026